Arthrosis Musculoskeletal Diseases Arthrosis
Conditions
Interventions
Four FMGs will be assigned to the AGIR program and two FMGs will be assigned to usual care.
The AGIR program includes specific educational workshops for community pharmacists and for healthcare profe
Sponsors
Canadian Institutes of Health Research (CIHR) (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Family medicine groups (FMGs) 1. Be located in Monteregie (Quebec, Canada) 2. Be located in a minimal distance of 25 km of another participating FMG 3. Refer 30 eligible patients of which at least 20 accept to participate in the study; and 4. Have at least two physicians, one nurse, two pharmacists and two physiotherapists who accept to participate in the study Patients: 1. Be 18 years or older 2. Have an arthrosis diagnosis since at least six months as confirmed by the primary care physician 3. Arthrosis is the main cause of pain 4. Feel arthrosis-associated pain at least two times per week 5. Describe the arthrosis-associated pain as at least 4 out of 10 on a scale where 0 represents ?no pain? and 10 represents ?the worst possible pain" 6. Have an usual community pharmacy located 10 km or less from the FMG 7. Speak and read French 8. Accept to participate in two educational workshops if the FMG is allocated to the AGIR program 9. Accept to participate in the study and sign the informed consent form Community pharmacies: 1. Be located less than 10 km from a participating FMG 2. Have at least one patient participating in the study 3. One pharmacist from this pharmacy accepts to represent the pharmacy by assisting to the AGIR workshop for healthcare professionals; and 4. Sign the informed consent form
Exclusion criteria
Exclusion criteria: Patients: 1. Report cancer-related chronic pain; and 2. Have dementia, an important psychiatric disorder or another medical condition preventing informed consent and/or the conduct of a telephone interview in the opinion of the physician or the nurse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative measurements: 1. Socio-demographic characteristics of patients, measured using a telephone questionnaire performed at study entry (T0) 2. Characteristics of arthrosis-related pain, measured using a telephone questionnaire performed at study entry (T0) and at the end of the follow-up (T8) 3. Patients? psychosocial functioning, measured using a self-administered questionnaire and a telephone questionnaire at T0 and T8 4. Patients? arthrosis-related knowledge and self-management, measured using a self-administered questionnaire and a telephone questionnaire at T0 and T8 5. Patients? physical activity, measured using a self-administered questionnaire at T0 and T8 6. Patients? use of healthcare services covered by the Régie de l?assurance maladie du Québec (RAMQ, Quebec?s general insurance program for medical and pharmaceutical services) six months preceding study entry and at T8, measured using the RAMQ administrative databases 7. Patients? use of healthcare services not covered by the RAMQ six months preceding study entry and at T8, measured using a telephone questionnaire at T0 and T8 8. Patients? pharmacotherapy six months preceding study entry and at T8, measured using the RAMQ administrative databases for patients covered by the RAMQ and using the reMed database for patients with private insurance plans 9. Patients? use of over-the-counter medications and natural products, measured using a telephone questionnaire at T0 and T8 10. Patients? satisfaction and expectations regarding their treatment, measured using a self-administered questionnaire at T0 and T8 11. Patients? risk of opioid addiction, measured using the self-administered questionnaire Opioid Risk Tool (ORT) at T0 12. Healthcare professionals? socio-demographic characteristics and actual practice, measured using self-administered questionnaire performed at T0 and T8 13. Healthcare professionals? pain-related knowledge, attitudes and beliefs, measured using the self-administered questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualitative measurements: 1. Perceptions of patients and healthcare professionals regarding the AGIR educational workshops and clinical tools, measured using qualitative interviews at the end of the follow-up (T8) 2. Perceptions of healthcare professionals regarding the medical services provided to patients following the AGIR educational workshops and the utility of the telephone service, measured using qualitative interviews at T8 3. Perceptions of patients regarding the medical services received following the AGIR educational workshops, measured using qualitative interviews at T8 | — |
Countries
Canada
Outcome results
None listed